Dec 4, 2018 Cellectar Initiates Cohort 6 of Phase 1b Trial Evaluating CLR 131 in Relapsed/Refractory Multiple Myeloma Learn More
Nov 13, 2018 Cellectar Reports Third Quarter 2018 Financial Results and Provides Business Update Learn More